Clinical Trial Aims to Measure Skin Color Change & Radiation
A clinical trial at NYU Langone’s Perlmutter Cancer Center aims to better understand radiation dermatitis in women with skin of color.
Clinical Trial Evaluates Next Generation Transcatheter Valve
Study evaluates the safety and effectiveness of an investigational self-expanding valve used in transcatheter aortic valve replacement surgery.
Clinical Trial Leads to Lifesaving Breast Cancer Treatment
Thanks to Dr. Sylvia Adams’s research, breast cancer patients at NYU Langone’s Perlmutter Cancer Center received early access to lifesaving care.
Clinical Trial Tests Adjuvant Immunotherapy for Melanoma
Dr. Jeffrey Weber, deputy director of NYU Langone's Perlmutter Cancer Center, leads a clinical trial for people with resected stage 3/4 melanoma.
Clinical Trial Tests Anti-Inflammatory Drug for COVID-19
Co-led by NYU Langone researchers, the COLCORONA trial examines whether colchicine can reduce complications for COVID-19–positive patients.
Clinical Trial Tests Antimalarial Drug to Prevent COVID-19
NYU Langone researchers are helping investigate whether the antimalarial medication hydroxychloroquine can help prevent COVID-19 infections.
Clinical Trial Tests Aquablation Therapy for Prostate Cancer
Dr. Herbert Lepor, a urologic oncologist at NYU Langone’s Perlmutter Cancer Center, leads a study of aquablation therapy for prostate cancer.
Clinical Trial Tests New Treatment for Bladder Cancer
Dr. William C. Huang, a urologic oncologist at NYU Langone’s Perlmutter Cancer Center, is leading a clinical trial for certain bladder cancers.
Clinical Trial Tests Noninvasive Glioblastoma Treatment
Dr. Dimitris G. Placantonakis, a neurosurgeon at NYU Langone’s Perlmutter Cancer Center, is testing a noninvasive treatment for glioblastoma.
Clinical Trial Tests Targeted Treatment for Bladder Cancer
A clinical trial at NYU Langone’s Perlmutter Cancer Center aims to treat bladder cancer without surgery.